bromodeoxyuridine has been researched along with Multiple Sclerosis in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, L; Hecker, J; Kerstetter, A; Miller, RH | 1 |
Chew, LJ; Fauveau, M; Gallo, V; Hong, E; Kerninon, C; Klopstein, A; Moll, NM; Nait Oumesmar, B; Naruse, M; Seilhean, D; Tepavcevic, V | 1 |
Daniels, BP; Klein, RS; Patel, JR; Williams, JL | 1 |
Amor, S; Baselmans, B; Bol, JG; Brevé, JJ; de Vries, HE; Deckard, SA; Drukarch, B; Dutta, R; Prins, M; Trapp, BD; van Dam, AM; van der Valk, P | 1 |
Borazanci, A; Gan, Y; Shi, FD; Shi, SX; Su, N; Zhu, X | 1 |
Ayuso-Sacido, A; Bronson, RT; Garcia-Verdugo, JM; Imitola, J; Khoury, SJ; Kivisäkk, P; Meyer, M; Rasmussen, S; Starossom, SC; Wang, Y; Zhu, B | 1 |
Ahmadiani, A; Heibatollahi, M; Javan, M; Mongabadi, S; Moradi, F; Sherafat, MA | 1 |
Rodriguez, M; Warrington, AE; Watzlawik, JO | 1 |
Keirstead, HS; Lane, TE; Nistor, GI; Totoiu, MO | 1 |
Bai, XF; Joshi, PS; Li, O; Liu, Y; Wang, Y; Zhang, H; Zheng, P; Zheng, X; Zhou, Q | 1 |
Brundin, L; Covacu, R; Danilov, AI; Johansson, CB; Langmoen, IA; Moe, MC; Olsson, T | 1 |
Barna, BP; Estes, ML; Jacobs, BS; McMahon, JT; Ransohoff, RM | 1 |
Freeman, JM | 1 |
13 other study(ies) available for bromodeoxyuridine and Multiple Sclerosis
Article | Year |
---|---|
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Topics: Animals; Animals, Newborn; Antigens; Bromodeoxyuridine; CD3 Complex; Cell Transplantation; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Neurons; Oligodendroglia; Organ Culture Techniques; Peptide Fragments; Proteoglycans; Proto-Oncogene Proteins c-sis; Recovery of Function; Spinal Cord; Time Factors | 2013 |
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Topics: Aged; Animals; Antigens; Autophagy-Related Proteins; Basic Helix-Loop-Helix Transcription Factors; Brain; Bromodeoxyuridine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Humans; Intracellular Signaling Peptides and Proteins; Leukocyte Common Antigens; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Middle Aged; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Myelin Basic Protein; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Proteoglycans; SOXF Transcription Factors; Time Factors; Up-Regulation | 2013 |
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Topics: Analysis of Variance; Animals; Axons; Benzylamines; Blotting, Western; Bromodeoxyuridine; Central Nervous System; Cyclams; Heterocyclic Compounds; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Real-Time Polymerase Chain Reaction; Receptors, CXCR; Receptors, CXCR4; Stem Cells | 2014 |
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.
Topics: Adenosine Triphosphate; Adult; Aged; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Female; Gene Expression; Gray Matter; Hippocampus; Histocompatibility Antigens Class II; Humans; Male; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Neuroglia; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Receptors, CCR2; White Matter | 2014 |
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Topics: Analysis of Variance; Annexin A5; Apoptosis; Bromodeoxyuridine; CD56 Antigen; Cell Proliferation; Cells, Cultured; Cytotoxicity, Immunologic; Dactinomycin; Female; Flow Cytometry; Humans; Interleukin-7; Interleukin-7 Receptor alpha Subunit; Killer Cells, Natural; Male; Multiple Sclerosis | 2014 |
Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.
Topics: Animals; Anti-Bacterial Agents; Bromodeoxyuridine; Cell Count; Cell Movement; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Mice; Microglia; Microscopy, Electron, Transmission; Minocycline; Multiple Sclerosis; Myelin Proteolipid Protein; Neural Stem Cells; Oligodendroglia; Peptide Fragments; Secondary Prevention; Stem Cell Niche; Time Factors | 2011 |
Electromagnetic field stimulation potentiates endogenous myelin repair by recruiting subventricular neural stem cells in an experimental model of white matter demyelination.
Topics: Animals; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Corpus Callosum; Disease Models, Animal; Electric Stimulation Therapy; Female; Intermediate Filament Proteins; Multiple Sclerosis; Myelin Basic Protein; Myelin Sheath; Nerve Degeneration; Nerve Regeneration; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Rats; Rats, Sprague-Dawley; Stem Cell Niche; Transcranial Magnetic Stimulation | 2012 |
PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Humans; Immunoglobulin M; Immunohistochemistry; Microscopy, Fluorescence; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Stem Cells; Thymidine | 2013 |
Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.
Topics: Animals; Axons; Bromodeoxyuridine; Cell Differentiation; Cell Movement; Cell Survival; Cells, Cultured; Disease Models, Animal; Graft Survival; Male; Mice; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Murine hepatitis virus; Myelin Sheath; Neostriatum; Neuroglia; Recovery of Function; Spinal Cord; Stem Cell Transplantation; Treatment Outcome | 2004 |
CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Antigens, CD; Apoptosis; Bone Marrow; Bromodeoxyuridine; CD24 Antigen; Central Nervous System; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Immunohistochemistry; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroglia; T-Lymphocytes; Time Factors | 2004 |
Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis.
Topics: Animals; Bromodeoxyuridine; Carbocyanines; Cell Differentiation; Cell Enlargement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; In Vitro Techniques; Membrane Potentials; Microscopy, Confocal; Multiple Sclerosis; Neurons; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Proliferating Cell Nuclear Antigen; Rats; Spinal Cord | 2006 |
Characterization of adult human astrocytes derived from explant culture.
Topics: Adult; Astrocytes; Bromodeoxyuridine; Bucladesine; Cell Line; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Microscopy, Electron; Multiple Sclerosis | 1990 |
Treatment of subacute sclerosing panencephalitis with 5-bromo-2-deoxyuridine and pyran copolymer.
Topics: Bromodeoxyuridine; Cerebral Cortex; Child; Diffuse Cerebral Sclerosis of Schilder; Electroencephalography; Encephalitis; Female; gamma-Globulins; Humans; Interferons; Male; Measles; Multiple Sclerosis; Polymers; Pyrans | 1968 |